RESEARCH-USE BIOSIMILAR ANTIBODY

Zinlirvimab

Monoclonal antibody · IgG1

HIV-1 gp120 V3IgG1RUO

Zinlirvimab is a human IgG1-λ2, HIV neutralising antibody targeting to HIV-1 gp120 envelope glycoprotein (IIIB gp120 V3 loop).

TARGETHIV-1 gp120 V3
YMonoclonal antibody
CATALOGSC-BS-016
CATALOG NUMBERSC-BS-016
MOLECULAR WEIGHTApprox. 143.58 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Zinlirvimab is a human IgG1-λ2, HIV neutralising antibody targeting to HIV-1 gp120 envelope glycoprotein (IIIB gp120 V3 loop).

Zinlirvimab is a human IgG1-λ2, HIV neutralising antibody targeting to HIV-1 gp120 envelope glycoprotein (IIIB gp120 V3 loop).

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte